Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Enanta Pharmaceuticals Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 06 Oct 2022 | Enanta Pharmaceuticals Inc Enters Phase I Clinical Trial Agreement with ICON Plc for EDP-235 (GDCT0470399) | Contract Service Agreement |
Enanta Pharmaceuticals Inc
Enanta Pharmaceuticals Inc |
ICON Plc ICON Plc |
| 06 Oct 2022 | Enanta Pharmaceuticals Inc Enters Phase I Clinical Trial Agreement with ICON Plc for EDP-235 (GDCT0470391) | Contract Service Agreement |
Enanta Pharmaceuticals Inc
Enanta Pharmaceuticals Inc |
ICON Plc ICON Plc |
| 29 Sep 2022 | Enanta Pharmaceuticals Inc Enters Phase I Clinical Trial Agreement with ICON Plc for EDP-323 (GDCT0444612) | Contract Service Agreement |
Enanta Pharmaceuticals Inc
|
ICON Plc |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer